MyFinsight
Home
About
Contact
supn: the income statement
Download
Download image
Net earnings (loss)
-$45,117K
(-217.20%↓ Y/Y)
Income tax expense
(benefit)
-$12,837K
(-299.15%↓ Y/Y)
Interest and other
income, net
$2,277K
(-44.44%↓ Y/Y)
Earnings (loss) before
income taxes
-$57,954K
(-228.95%↓ Y/Y)
Total other income
(expense), net
$2,277K
(-44.44%↓ Y/Y)
Royalty License And
Other Revenue
$3,397K
Collaboration Revenue
$20,164K
Product
$168,542K
Operating earnings (loss)
-$60,231K
(-247.46%↓ Y/Y)
Total revenues
$192,103K
(9.34%↑ Y/Y)
Total costs and
expenses
$252,334K
(87.13%↑ Y/Y)
Amortization of intangible
assets
$24,325K
(24.82%↑ Y/Y)
Selling, general and
administrative
$179,678K
(157.59%↑ Y/Y)
Research and development
$29,366K
(1.14%↑ Y/Y)
Cost of revenues
$18,965K
(7.86%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
SUPERNUS PHARMACEUTICALS, INC. (SUPN)